Skip to main content

Articles

Page 10 of 17

  6. Authors: Gwen Lapham, Megan Addis, Amy Lee, Carol Achtmeyer, Julie Richards, Evette Ludman, Tory Gildred, Ryan Caldeiro, Larry Marx, Paula Lozano and Katharine A Bradley
    Citation: Addiction Science & Clinical Practice 2015 10(Suppl 2):O40
    Content type: Oral presentation Published on:

    This article is part of a Supplement: Volume 10 Supplement 2

  10. Authors: Pierluigi Struzzo, Roberto Della Vedova, Donatella Ferrante, Nicholas Freemantle, Charilaos Lygidakis, Francesco Marcatto, Emanuele Scafato, Francesca Scafuri, Costanza Tersar and Paul Wallace
    Citation: Addiction Science & Clinical Practice 2015 10(Suppl 2):O29
    Content type: Oral presentation Published on:

    This article is part of a Supplement: Volume 10 Supplement 2

  12. Authors: Shannon Gwin Mitchell, Arethusa S Kirk, Marla Oros, Jan Gryczynski, Kristi Dusek, Colleen Hosler, Robert P Schwartz, Barry S Brown, Carolina Barbosa, Laura J Dunlap, David W Lounsbury and Kevin E O'Grady
    Citation: Addiction Science & Clinical Practice 2015 10(Suppl 2):O24
    Content type: Oral presentation Published on:

    This article is part of a Supplement: Volume 10 Supplement 2

  18. Authors: Alexander Cowell, Gary A Zarkin, Brendan Wedehase, Scott T Walters and Faye S Taxman
    Citation: Addiction Science & Clinical Practice 2015 10(Suppl 2):O13
    Content type: Oral presentation Published on:

    This article is part of a Supplement: Volume 10 Supplement 2

  21. Authors: Emily Williams, CE Achtmeyer, JP Young, KA Bradley, D Berger, MB Siegel, G Curran, EJ Ludman, GT Lapham, AHS Harris and M Forehand
    Citation: Addiction Science & Clinical Practice 2015 10(Suppl 2):P12
    Content type: Poster presentation Published on:

    This article is part of a Supplement: Volume 10 Supplement 2

  25. Authors: Carolina Barbosa, Laura J Dunlap, Brendan Wedehase, Shannon Gwin Mitchell, Robert P Schwartz, Kristi Dusek, Arethusa S Kirk, Marla Oros, Colleen Hosler, Jan Gryczynski and Barry S Brown
    Citation: Addiction Science & Clinical Practice 2015 10(Suppl 2):O5
    Content type: Oral presentation Published on:

    This article is part of a Supplement: Volume 10 Supplement 2

  30. Driving under the influence (DUI) is a significant problem, and there is a pressing need to develop interventions that reduce future risk.

    Authors: Karen Chan Osilla, Susan M. Paddock, Thomas J. Leininger, Elizabeth J. D’Amico, Brett A. Ewing and Katherine E. Watkins
    Citation: Addiction Science & Clinical Practice 2015 10:18
    Content type: Research Published on:

  31. Homelessness, substance use, and mental disorders each have been associated with higher rates of emergency department (ED) use and hospitalization. We sought to understand the correlation between ED use, hospi...

    Authors: Adrienne Cheung, Julian M Somers, Akm Moniruzzaman, Michelle Patterson, Charles J Frankish, Michael Krausz and Anita Palepu
    Citation: Addiction Science & Clinical Practice 2015 10:17
    Content type: Research Published on:

  32. When opioid-agonist treatments were approved in France in 1995, opiate use disorders began to be managed and treated by general practitioners (GPs), who have since then been encouraged to treat substance use d...

    Authors: Pierre Poloméni, Claude Bronner, Fréderic Fry, Bruno Ravoninjatovo and Mélina Fatseas
    Citation: Addiction Science & Clinical Practice 2015 10:16
    Content type: Research Published on:

  33. Individuals with substance use disorders can receive important abstinence-specific support in 12-step groups (TSGs). However, our understanding of key factors that influence TSG participation remains limited. ...

    Authors: John-Kåre Vederhus, Sarah E. Zemore, Jostein Rise, Thomas Clausen and Magnhild Høie
    Citation: Addiction Science & Clinical Practice 2015 10:15
    Content type: Research Published on:

  34. Telemedicine use in addiction treatment and recovery services is limited. Yet, because it removes barriers of time and distance, telemedicine offers great potential for enhancing treatment and recovery for peo...

    Authors: Todd Molfenter, Mike Boyle, Don Holloway and Janet Zwick
    Citation: Addiction Science & Clinical Practice 2015 10:14
    Content type: Case Study Published on:

  35. Various hospital accreditation and quality assurance entities in the United States have approved and endorsed performance measures promoting alcohol brief intervention (BI) for hospitalized individuals who scr...

    Authors: Lauren M Broyles, Melissa E Wieland, Andrea L Confer, Monica M DiNardo, Kevin L Kraemer, Barbara H Hanusa, Ada O Youk, Adam J Gordon and Mary Ann Sevick
    Citation: Addiction Science & Clinical Practice 2015 10:13
    Content type: Study Protocol Published on:

  36. Although opioid-agonist therapy with methadone or buprenorphine/naloxone is currently the mainstay of medical treatment for opioid use disorder, these medications often are not well accepted or tolerated by pa...

    Authors: Keith Ahamad, MJ Milloy, Paul Nguyen, Sasha Uhlmann, Cheyenne Johnson, Todd P Korthuis, Thomas Kerr and Evan Wood
    Citation: Addiction Science & Clinical Practice 2015 10:12
    Content type: Research Published on:

  38. The present investigation aimed to provide an objective narrative review of the existing literature pertaining to the benefits and harms of marijuana use for the treatment of the most common medical and psycho...

    Authors: Katherine A Belendiuk, Lisa L Baldini and Marcel O Bonn-Miller
    Citation: Addiction Science & Clinical Practice 2015 10:10
    Content type: Review Published on:

  39. Recent designer drugs, also known as “legal highs,” include substituted cathinones (e.g., mephedrone, methylone, and methylenedioxypyrovalerone, often referred to as “bath salts”); synthetic cannabinoids (SCs;...

    Authors: Michael F Weaver, John A Hopper and Erik W Gunderson
    Citation: Addiction Science & Clinical Practice 2015 10:8
    Content type: Review Published on:

  40. Patient-centered models of assessment have shown considerable promise for increasing patients’ readiness for mental health treatment in general, but have not been used to facilitate patients’ engagement in sub...

    Authors: Daniel M Blonigen, Christine Timko, Theodore Jacob and Rudolf H Moos
    Citation: Addiction Science & Clinical Practice 2015 10:9
    Content type: Research Published on:

  42. Treating alcohol use disorders (AUD) is critical in individuals suffering from hepatitis C infection (HCV). Aside from psychosocial interventions, pharmacological treatment is effective for decreasing alcohol ...

    Authors: Alexis Thibault, Suzanne Brissette and Didier Jutras-Aswad
    Citation: Addiction Science & Clinical Practice 2015 10:6
    Content type: Review Published on:

  43. University students have high levels of tobacco and other drug use, yet they are unlikely to seek traditional care. Technology-based interventions are highly relevant to this population. This paper comprises a...

    Authors: Amelia Gulliver, Louise Farrer, Jade KY Chan, Robert J Tait, Kylie Bennett, Alison L Calear and Kathleen M Griffiths
    Citation: Addiction Science & Clinical Practice 2015 10:5
    Content type: Research Published on:
Submit manuscript

Follow

Affiliated with

Annual Journal Metrics

  • 2022 Citation Impact
    3.7 - 2-year Impact Factor
    4.4 - 5-year Impact Factor
    0.956 - SNIP (Source Normalized Impact per Paper)
    1.166 - SJR (SCImago Journal Rank)

    2023 Speed
    25 days submission to first editorial decision for all manuscripts (Median)
    202 days submission to accept (Median)

    2023 Usage 
    755,413 downloads
    622 Altmetric mentions

Archival content

Addiction Science & Clinical Practice was formerly published by NIDA and previous issues of the journal can be viewed here.

Addiction Science & Clinical Practice

ISSN: 1940-0640